COLOGNE, GERMANY and PHILADELPHIA, PA / ACCESSWIRE / February 2, 2021 / CEVEC Pharmaceuticals GmbH (CEVEC) and CARISMA Therapeutics Inc. (CARISMA) today announced the signing of an agreement which ...

COLOGNE, GERMANY / ACCESSWIRE / February 9, 2017 / CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced ...

Cologne, Germany, December 21, 2010 / b3c newswire / - CEVEC Pharmaceuticals, the developer of the CAP® protein expression system derived from human amniocytes, today announced that Rainer Christine ...

Cologne, Germany, May 26, 2010 / b3c newswire / - CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive ...

ELEVECTA(R) takes viral vector manufacturing to the next level to serve the rapidly growing market of gene therapy applications Growing serum-free in suspension, ELEVECTA(R) producer cell lines enable ...

CEVEC Pharmaceuticals has announced its new management team: Wolfgang Kintzel remains Chief Executive Officer, Dr. Nicole Faust is appointed Chief Scientific Officer, Dr. Hartmut Tintrup is appointed ...

CAP-T system will be used to manufacture protein antigen being evaluated in preclinical studies. Swiss vaccines company Pevion Biotech negotiated an exclusive license option agreement with Cevec ...

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities. Cytiva has acquired CEVEC Pharmaceuticals, a Germany-based provider of ...

CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced a collaboration agreement with Généthon (Evry, ...

Jed Seifert says his greatest moment of last year was the day he walked into Stakes Manufacturing in Eastlake to see an older couple he didn’t recognize. After introductions were made, Seifert learned ...